These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6135746)

  • 21. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.
    Arora RC; Meltzer HY
    J Neural Transm Gen Sect; 1991; 85(1):19-29. PubMed ID: 1678267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
    Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
    Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.
    Singh AN; Barlas C; Singh S; Franks P; Mishra RK
    J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
    Leysen JE; Niemegeers CJ; Van Nueten JM; Laduron PM
    Mol Pharmacol; 1982 Mar; 21(2):301-14. PubMed ID: 7099138
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Life Sci; 2000; 66(25):2455-64. PubMed ID: 10894088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
    Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
    Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine D2 receptors in substantia nigra in schizophrenia.
    Owen R; Owen F; Poulter M; Crow TJ
    Brain Res; 1984 May; 299(1):152-4. PubMed ID: 6144367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.
    Reynolds GP; Arnold L; Rossor MN; Iversen LL; Mountjoy CQ; Roth M
    Neurosci Lett; 1984 Jan; 44(1):47-51. PubMed ID: 6717852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM; Janssen PF; Leysen JE
    Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.
    Luabeya MK; Maloteaux JM; Laduron PM
    J Neurochem; 1984 Oct; 43(4):1068-71. PubMed ID: 6088690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
    Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association between uptake to lymphocytes from schizophrenic patients and therapeutic efficacy].
    Shimogawa S; Kaku H; Yoshimoto S; Nakane Y
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):239-46. PubMed ID: 2877529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
    Treiman M; Andersen PH
    J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.
    Lewis R; Kapur S; Jones C; DaSilva J; Brown GM; Wilson AA; Houle S; Zipursky RB
    Am J Psychiatry; 1999 Jan; 156(1):72-8. PubMed ID: 9892300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of molecular action of neuroleptics].
    de Erausquin GA
    Vertex; 2003; 14(51):36-44. PubMed ID: 12690408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptors and schizophrenia: the neuroleptic drug problem.
    Reynolds GP; Riederer P; Jellinger K; Gabriel E
    Neuropharmacology; 1981 Dec; 20(12B):1319-20. PubMed ID: 6119642
    [No Abstract]   [Full Text] [Related]  

  • 40. Solubilized serotonin receptors from rat and dog brain. Selective labelling with [3H]ketanserin.
    Ilien B; Schotte A; Laduron PM
    FEBS Lett; 1982 Feb; 138(2):311-5. PubMed ID: 6121721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.